Company intelligence / Profile preview

JMS Holdings

Hiroshima, Japan

Ownership: Private
Employees: ~5469
Development stage: Other

Overview

JMS is an established commercial-stage medical device company with a 60-year history. The company has successfully commercialized products across dialysis, infusion, blood management, and cardiovascular therapies with global distribution to over 60 countries.

Therapeutic areas: HematologyNephrologyOtherCardiovascularGastroenterologyOncology
Modalities: Device
Industry: Therapeutic Medical Devices

Partnerships

Teijin Pharma Limited (home medical care joint venture)Otsuka Pharmaceutical Factory, Inc. (J.O.Pharma joint venture)Japan Aerospace Exploration Agency (JAXA) (space research applications)Japanese Red Cross Society (blood bag supply)Asahi Kasei Medical Co., Ltd. (acquired transfusion technology business)

Beyond the preview

Go deeper on JMS Holdings.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on JMS Holdings.

Explore the full profile